Cargando…
Screening for regenerative therapy responders in heart failure
Risk of outcome variability challenges therapeutic innovation. Selection of the most suitable candidates is predicated on reliable response indicators. Especially for emergent regenerative biotherapies, determinants separating success from failure in achieving disease rescue remain largely unknown....
Autores principales: | Yamada, Satsuki, Jeon, Ryounghoon, Garmany, Armin, Behfar, Atta, Terzic, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252977/ https://www.ncbi.nlm.nih.gov/pubmed/34169733 http://dx.doi.org/10.2217/bmm-2020-0683 |
Ejemplares similares
-
Mass Customized Outlook for Regenerative Heart Failure Care
por: Yamada, Satsuki, et al.
Publicado: (2021) -
Regenerative heart failure therapy headed for optimization
por: Terzic, Andre, et al.
Publicado: (2014) -
Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy
por: Yamada, Satsuki, et al.
Publicado: (2019) -
Clinical development plan for regenerative therapy in heart failure
por: Terzic, Andre, et al.
Publicado: (2016) -
Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome
por: Arrell, D. Kent, et al.
Publicado: (2021)